MedTrace Logo

Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression

NCT02035878 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2014-01-14

No results posted yet for this study

Summary

The proposed project will investigate the effects of probiotics on anxiety and associated psychological and physiological factors in humans. The therapeutic potential of probiotics for reducing anxiety and other factors associated with a disrupted microbiome will be assessed in a double-blind placebo-crossover design. Based on the research findings to date, it is hypothesized that probiotics will reduce anxiety and depressive symptoms.

Conditions

Interventions

OTHER

Probiotics

probiotic intervention: 400mg of probiotic capsule

DRUG

Placebo

placebo comparator

Sponsors & Collaborators

  • Acadia University

    lead OTHER

Principal Investigators

  • Dr. Susan Potter, PhD · Acadia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-10-31
Completion
2014-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035878 on ClinicalTrials.gov